Arteris officer Moll proposes $807K share sale
The notice lists 9,219 shares sold on September 14, 2026, during the prior three months, with $192,222.60 shown for that entry.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Arteris, Inc. (AIP) officer Laurent Moll reported a proposed sale of 32,713 common shares, with an aggregate market value of $806,702.58 and an approximate sale date of October 5, 2026. Morgan Stanley Smith Barney LLC is identified as the broker, and the notice reports 49,152,102 shares outstanding.
The securities table lists 3,000 shares under the Employee Stock Purchase Plan and 29,713 shares associated with Restricted Stock Units. Separately, the remarks state that the securities to be sold were acquired upon vesting of restricted stock units from April 1, 2024 through October 1, 2026.
Key Figures
Key Terms
Employee Stock Purchase Plan financial
Restricted Stock Units financial
Rule 144 regulatory
10b5-1 Sales regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What prior sales are reported for Arteris (AIP) officer Laurent Moll?
AI-generated analysis. How Rhea-AI works. Not financial advice.